| Lapatinib studied in …STUDIED_INderived200 of 222show all (up to 200) |
|---|
| → studied in | NCT00770809Phase 3 · completed Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02029001Phase 2 · recruiting Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment · 222 trials list this drug (4 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273610Phase 2 · active not recruiting Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01947023Phase 1 · active not recruiting Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery · 222 trials list this drug (4 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03784014Phase 3 · completed Molecular Profiling of Advanced Soft-tissue Sarcomas · 222 trials list this drug (4 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01612351Phase 2 · completed Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery · 222 trials list this drug (4 active) | — | — | Malignant Head and Neck Neoplasm,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03523585Phase 3 · completed DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02] · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01382706Phase 2 · terminated Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder · 222 trials list this drug (4 active) | — | — | Bladder Neoplasm,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00680901Phase 3 · completed LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib · 222 trials list this drug (4 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02230553Phase 1/Phase 2 · completed Lapatinib Plus Trametinib in KRAS Mutant NSCLC · 222 trials list this drug (4 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01526369Phase 3 · completed A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00490139Phase 3 · completed ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00667251Phase 3 · completed Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00999804Phase 2 · active not recruiting Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01160211Phase 3 · completed A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470704Phase 2 · completed Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101905Phase 1 · completed Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma · 222 trials list this drug (4 active) | — | — | Mixed Glioma,Anaplastic Astrocytoma,Anaplastic Ependymoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01306045Phase 2 · completed Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies · 222 trials list this drug (4 active) | — | — | Thymus Carcinoma,Lung Non-Small Cell Carcinoma,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00963547Phase 1 · terminated A Study of MK-2206 in Combination With Trastuzumab and Lapatinib for the Treatment of HER2+ Solid Tumors (MK-2206-015) · 222 trials list this drug (4 active) | — | — | Solid Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00424164Phase 1 · completed Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03500380Phase 2/Phase 3 · unknown A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases · 222 trials list this drug (4 active) | — | — | Breast Neoplasm,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01300962Phase 1 · completed Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01622868Phase 2 · completed Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Carcinoma,Invasive Breast Carcinoma,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01711658Phase 2 · completed TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. · 222 trials list this drug (4 active) | — | — | Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01873833Phase 2 · terminated Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04591431Phase 2 · unknown The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm,Malignant Digestive System Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00455039Phase 1/Phase 2 · withdrawn INST 0514C- Biologic Correlative Study: Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01138384Phase 1/Phase 2 · completed Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03084939Phase 3 · completed Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00272987Phase 3 · terminated ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00841828Phase 2 · completed Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00281658Phase 3 · completed Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2 · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00436566Phase 2 · completed Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00447122Phase 1 · terminated BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer · 222 trials list this drug (4 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01499160Phase 2 · terminated Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00952692Phase 1/Phase 2 · completed Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00444535Phase 2 · completed Lapatinib and Bevacizumab for Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02213042Phase 2 · terminated Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00206427Phase 2 · completed Neoadjuvant GW572016 to Treat Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02073487Phase 2 · completed Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00508274Phase 3 · terminated Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00553358Phase 3 · completed Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01808573Phase 3 · completed A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting · 222 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01636908NA · completed Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies. · 222 trials list this drug (4 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00073528Phase 3 · completed Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00863122early Phase 1 · completed Concentration and Activity of Lapatinib in Vestibular Schwannomas · 222 trials list this drug (4 active) | — | — | Vestibular Schwannoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00367471Phase 1 · completed Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer. · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01875666early Phase 1 · completed Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00883688Phase 2 · completed Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma · 222 trials list this drug (4 active) | — | — | Childhood Malignant Neoplasm,Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085020Phase 1 · completed GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00543504Phase 1 · completed Bevacizumab in Multiple Phase I Combinations · 222 trials list this drug (4 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00684983Phase 2 · completed Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01044433Phase 2 · completed Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck · 222 trials list this drug (4 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Salivary Gland Neoplasm,Laryngeal Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00331630early Phase 1 · completed Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00939523Phase 2 · completed Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy · 222 trials list this drug (4 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00390455Phase 3 · completed Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive · 222 trials list this drug (4 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Breast Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00574171Phase 2 · completed Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma · 222 trials list this drug (4 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01827163Phase 2 · completed Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer · 222 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00263588Phase 2 · completed Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04185649Phase 3 · unknown The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer · 222 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01118975Phase 1/Phase 2 · terminated GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers · 222 trials list this drug (4 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01264081Phase 2 · terminated Lapatinib in Stage IV Melanoma With ERBB4 Mutations · 222 trials list this drug (4 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01783756Phase 1/Phase 2 · completed Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00548184Phase 2 · completed Lapatinib and Trastuzumab With or Without Endocrine Therapy · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00820872Phase 2 · completed Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01891357Phase 2 · terminated Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Ductal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096447Phase 2 · completed Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer · 222 trials list this drug (4 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00113373Phase 2 · completed Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer · 222 trials list this drug (4 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02294786Phase 2 · terminated Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00759642Phase 2 · terminated Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00968968Phase 3 · terminated Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone · 222 trials list this drug (4 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01434303Phase 1 · completed Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Only · 222 trials list this drug (4 active) | — | — | Breast Neoplasm,Breast Carcinoma,Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02073916Phase 1 · completed T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00820222Phase 3 · completed Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00826241Phase 2 · completed Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma · 222 trials list this drug (4 active) | — | — | Spinal Cord Neoplasm,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00320411Phase 2 · completed GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01973660Phase 2 · completed PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00477464Phase 2 · completed Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01104571Phase 3 · unknown Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00953576Phase 1/Phase 2 · terminated Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer · 222 trials list this drug (4 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00371488Phase 1 · completed GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00462956Phase 1 · completed GW572016 In Patients With Advanced Or Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00777101Phase 2 · completed Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00225758Phase 2 · terminated Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00498953Phase 1/Phase 2 · completed Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx · 222 trials list this drug (4 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02422199Phase 1/Phase 2 · unknown A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab · 222 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107003Phase 2 · completed GW572016 to Treat Recurrent Malignant Brain Tumors · 222 trials list this drug (4 active) | — | — | Glioblastoma,Glioma,Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02836847Phase 2 · unknown Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma · 222 trials list this drug (4 active) | — | — | Gallbladder Neoplasm,Malignant Gallbladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101036Phase 2 · completed Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery · 222 trials list this drug (4 active) | — | — | Malignant Gallbladder Neoplasm,Adult Hepatocellular Carcinoma,Malignant Extrahepatic Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00555152NA · completed Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ · 222 trials list this drug (4 active) | — | — | Breast Ductal Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00790816Phase 1 · completed Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02015169Phase 2 · completed Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis · 222 trials list this drug (4 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00404066Phase 2 · completed Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00536809Phase 1 · completed Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer · 222 trials list this drug (4 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00148902Phase 1 · completed Effects Of GW572016 In Combination With Docetaxel (TAXOTERE) · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00258050Phase 1 · completed To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118157Phase 2 · completed Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00158782Phase 1 · completed Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients · 222 trials list this drug (4 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00169533Phase 1 · completed Rollover Study Of Lapatinib In Cancer Patients · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00388076Phase 1 · completed Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB) · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00528281Phase 1 · completed A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase · 222 trials list this drug (4 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00650910Phase 1 · completed Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00849329Phase 1 · completed A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00359190Phase 1 · completed Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00516672Phase 1 · completed Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors · 222 trials list this drug (4 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00821054Phase 1 · completed A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00996762Phase 1 · completed A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01290354Phase 1 · completed Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02338245Phase 2 · completed Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01688609Phase 2 · completed Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03273595Phase 2 · unknown Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01934894Phase 2 · terminated Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases · 222 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00246753Phase 2 · completed Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy · 222 trials list this drug (4 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01868503Phase 2 · terminated Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01205217Phase 2 · withdrawn Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00111787Phase 2 · completed Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01013740Phase 2 · completed Lapatinib in Combination With Vinorelbine · 222 trials list this drug (4 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00482391Phase 2 · completed Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01332396completed Drug Use Investigation for TYKERB Tablet (All Case Investigation) · 222 trials list this drug (4 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095563Phase 2 · completed Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers · 222 trials list this drug (4 active) | — | — | Salivary Gland Neoplasm,Malignant Salivary Gland Neoplasm,Oral Cavity Adenoid Cystic Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00662636Phase 1 · completed Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery · 222 trials list this drug (4 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00379509Phase 1 · completed Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00496366Phase 2 · terminated Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00490061Phase 2 · terminated Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy · 222 trials list this drug (4 active) | — | — | Malignant Head and Neck Neoplasm,Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00073008Phase 2 · terminated A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer · 222 trials list this drug (4 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089999Phase 2 · completed Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02342587Phase 2 · completed Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced Cancer · 222 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450203Phase 2/Phase 3 · unknown Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer · 222 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00524303Phase 2 · completed Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy. · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01172223Phase 1/Phase 2 · completed Primary Chemotherapy in Patients With HER2-positive Early Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00829166Phase 3 · completed A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01123473Phase 2 · terminated Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer · 222 trials list this drug (4 active) | — | — | Malignant Gastric Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02238509Phase 2 · unknown Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02394496Phase 3 · unknown Overcoming Endocrine Resistance in Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01769508Phase 2 · terminated Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer · 222 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01328054Phase 4 · completed A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval · 222 trials list this drug (4 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00486668Phase 3 · unknown A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer · 222 trials list this drug (4 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00422903Phase 2 · completed Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01454804Phase 1 · completed Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors · 222 trials list this drug (4 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00429299Phase 2 · completed Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00973739Phase 2 · completed Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors · 222 trials list this drug (4 active) | — | — | Vestibular Schwannoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00320385Phase 3 · completed Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00347919Phase 2 · completed Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00753207Phase 1 · completed Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30 · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00769470Phase 2 · completed Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00343759Phase 2 · withdrawn Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01087983Phase 1 · completed Lapatinib With Sirolimus or Metformin · 222 trials list this drug (4 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01495884Phase 1/Phase 2 · terminated The Myocet/Lapatinib Study. ICORG 10-03, V5 · 222 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00437073Phase 2 · terminated Brain Metastases In ErbB2-Positive Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01068704Phase 2 · completed Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00898573withdrawn Lapatinib Resistance in Patients With Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00105950Phase 2 · completed Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00694252Phase 2 · completed Lapatinib and Circulating Tumor Cells in Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00754702Phase 2 · terminated Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01281163Phase 1 · terminated Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00857714NA · terminated Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast · 222 trials list this drug (4 active) | — | — | Breast Ductal Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01427322early Phase 1 · terminated Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease · 222 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387127Phase 2 · completed Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer · 222 trials list this drug (4 active) | — | — | Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00632489Phase 1 · completed LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer Patients · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00430781Phase 2 · completed Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer · 222 trials list this drug (4 active) | — | — | Cervical Neoplasm,Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075270Phase 3 · completed Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107536Phase 2 · completed Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer · 222 trials list this drug (4 active) | — | — | Malignant Gallbladder Neoplasm,Adult Hepatocellular Carcinoma,Malignant Extrahepatic Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062686Phase 2 · completed GW572016 For Treatment Of Refractory Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00114283Phase 2 · completed Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer · 222 trials list this drug (4 active) | — | — | Malignant Salivary Gland Neoplasm,Laryngeal Squamous Cell Carcinoma,Laryngeal Verrucous Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00949455Phase 2/Phase 3 · unknown A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium · 222 trials list this drug (4 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01462552completed Physician Liver Function Test (LFT) Monitoring for Tykerb Pts · 222 trials list this drug (4 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352443Phase 1 · completed S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma · 222 trials list this drug (4 active) | — | — | Adult Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00962312Phase 2 · completed Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer · 222 trials list this drug (4 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01218529Phase 2 · completed Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors · 222 trials list this drug (4 active) | — | — | Breast Neoplasm,Lung Neoplasm,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01666431Phase 2 · terminated Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment · 222 trials list this drug (4 active) | — | — | Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00756470Phase 2 · terminated Phase II Neoadjuvant in Inflammatory Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00975988completed Regulatory TYKERB® Tablets PMS · 222 trials list this drug (4 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01245205Phase 1 · completed Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer · 222 trials list this drug (4 active) | — | — | Adult Solid Neoplasm,Malignant Breast Neoplasm,Male Breast Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00103194Phase 2 · completed Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer · 222 trials list this drug (4 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00374322Phase 3 · completed Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00356811Phase 2 · completed Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00424255Phase 3 · completed Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery · 222 trials list this drug (4 active) | — | — | Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00044343Phase 2 · completed GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin · 222 trials list this drug (4 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00313599Phase 1 · completed Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors · 222 trials list this drug (4 active) | — | — | Extragonadal Germ Cell Tumor,Malignant Breast Neoplasm,Malignant Esophageal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00544804Phase 1 · completed Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2 · 222 trials list this drug (4 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01145404Phase 2 · terminated Trial of Lapatinib Versus Lapatinib With Capecitabine in Her2+ Metastatic Gastro-Esophageal Cancer · 222 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00623064Phase 1 · completed Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer · 222 trials list this drug (4 active) | — | — | Bladder Neoplasm,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095940Phase 1/Phase 2 · completed Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors · 222 trials list this drug (4 active) | — | — | Childhood Anaplastic Astrocytoma,Childhood Giant Cell Glioblastoma,Childhood Glioblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470847Phase 1 · completed Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00436644Phase 2 · completed Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin · 222 trials list this drug (4 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01730677Phase 2 · unknown Lapatinib+Vinorelbine vs Vinorelbine HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib/Trastuzumab · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01477060Phase 2 · terminated Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00099060Phase 1/Phase 2 · completed Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme · 222 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00513058Phase 1 · completed Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098631Phase 2 · completed Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer · 222 trials list this drug (4 active) | — | — | Laryngeal Squamous Cell Carcinoma,Salivary Gland Squamous Cell Carcinoma,Hypopharyngeal Squamous Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00826267Phase 2 · completed 6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00316875Phase 1 · completed Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01705340Phase 1 · terminated Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm,Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00688194Phase 3 · unknown Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00795678completed Chemotherapeutic Agents in Brain/Breast · 222 trials list this drug (4 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01557764Phase 2 · withdrawn Lapatinib With Trastuzumab in Treating Patients With HER2-Negative/HER2 Mutant Metastatic Breast Cancer · 222 trials list this drug (4 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00486954Phase 3 · completed Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer · 222 trials list this drug (4 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098605Phase 2 · completed Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases · 222 trials list this drug (4 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095667Phase 2 · completed Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer · 222 trials list this drug (4 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00350727Phase 2 · completed Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma · 222 trials list this drug (4 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |